Wujia Yizhi granules for mild-to-moderate Alzheimer's
Part of Brain & nervous system, Mental health clinical trials.
This trial tests if a Chinese herbal granule (Wujia Yizhi) can help people with mild-to-moderate Alzheimer's dementia. It is for patients who have memory problems for at least 6 months and meet specific Alzheimer's biomarker criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 80 years old.
- You have been diagnosed with mild-to-moderate Alzheimer's dementia for at least 6 months.
- You have proof of Alzheimer's-related brain changes (from a PET scan or spinal fluid test).
- Your memory and thinking test scores fall within a certain range.
- You do not have other types of dementia, a history of seizures, or active psychiatric conditions.
- You are not currently taking antidepressants, anxiety meds, or antipsychotics.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 trial tests whether a medicine called sodium oligomannate (GV-971) is safe and effective for people with mild to moderate Alzheimer’s disease. It may help slow or improve memory and thinking symptoms while carefully tracking side effects.
This trial tests a new medicine, VHB937, in people with early Alzheimer's (mild cognitive impairment or mild dementia). The goal is to see if it can slow down memory loss and thinking problems.
This trial tests if a supplement called genistein can help people with mild memory problems caused by early Alzheimer's disease. You must have a brain scan showing amyloid buildup and be otherwise healthy enough to participate.
This study tests whether Huperzine A controlled-release tablets can help improve memory and thinking in people with mild-to-moderate Alzheimer's disease. You'll take the tablets or a placebo to see if it slows down dementia symptoms.
This study tests a new drug, QLH2405, for people with mild cognitive impairment or mild Alzheimer's disease. It aims to see if the drug is safe and how it affects memory and thinking.
This trial tests whether silkworm pupa powder can help slow memory loss and thinking problems in people with mild-to-moderate Alzheimer's disease. Researchers will check if it works by measuring changes in memory, thinking ability, and brain markers over time.
Hear when a new Alzheimer's Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.